borderline non-significantP = 0.050
Five studies evaluated cranial radiation therapy (CRT) as a risk factor for MetS, with three case–control studies showed a borderline non-significant association (OR: 1.79, 95% CI: 1.00–3.20, P = 0.050), while cohort studies identified it as a significant risk factor (RR: 1.72, 95% CI: 1.22–2.41, P = 0.002).